ConductScience.org, home

Paper11854792

Absorption and Malabsorption of Levothyroxine Sodium.

Sherman SI and 1 other. Am J Ther, 1995. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Absorption and Malabsorption of Levothyroxine Sodium. Papers, record 11854792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11854792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Absorption and Malabsorption of Levothyroxine Sodium.
PubMed
Journal
Am J Ther
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2019-11-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sherman SISteven I.
2Malecha SESusan E.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01189344Levothyroxine (L-T4) Absorption After Bariatric SurgeryBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
38260167Levothyroxine personalized treatment: is it still a dream?Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/38260167PubMed
36561558Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36561558PubMed
27272506TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.Obes Surg2017https://conductscience.org/library/papers/27272506PubMed
26965518Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.BMC Gastroenterol2016https://conductscience.org/library/papers/26965518PubMed
24789541Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube.J Endocrinol Invest2014https://conductscience.org/library/papers/24789541PubMed
21633823Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.Obes Surg2012https://conductscience.org/library/papers/21633823PubMed
16120075Effects of grapefruit juice on the absorption of levothyroxine.Br J Clin Pharmacol2005https://conductscience.org/library/papers/16120075PubMed
10693372How medications affect thyroid function.West J Med2000https://conductscience.org/library/papers/10693372PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11854792

GET https://conductscience.org/api/papers/v1/11854792/authors